The offers continue to come in for UK companies with one of our Stonking Small Caps on the receiving end on this occasion and another AIM-listed technology group also receiving an approach. Elsewhere, a fast-growing software group has reported impressive results, while a veterinary services business can breathe a sigh of relief on a seemingly favourable outcome to a CMA review into the sector. Read on here for our usual forthright views from the small cap world.
CVS: shares climb on favourable CMA outcome
Shares in veterinary group CVS (AIM:CVSG) have climbed on news of a more favourable outcome than some had clearly anticipated to the Competition and Markets Authority (‘CMA’) review of the UK veterinary sector.
The CMA’s review has come to the broad conclusion that pet owners should receive better and more transparent information on prices, treatment options, services, ownership, and other basic information. The CMA also proposes greater…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.
